Current Affairs - Miscellaneous - Discussion

Vaccine manufacturer Bharat Biotech and Thomas Jefferson University of Philadelphia have signed an exclusive deal to develop a new vaccine candidate for COVID-19 at Jefferson with the support from the Department of Biotechnology, Bharat Biotech aims for human trials in early December 2020. This vaccine was developed in January 2020 at Infectious diseases expert Professor Matthias Schnell's lab and completed the preliminary tests in animal models. The mice which received the vaccine showed strong antibody response.